Juvenile Idiopathic Arthritis (JIA) Registry
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- AbbVie
- Study ID
- NCT00783510
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- adalimumab — BIOLOGICALAs prescribed by treating physician
- Methotrexate — DRUGAs prescribed by treating physician
Study Details
This is a global registry, to evaluate the long-term safety of Humira® in patients with moderate to severe polyarticular Juvenile Idiopathic Arthritis (JIA), that are treated as recommended in the Humira® product label. Patients treated with MTX will be considered a reference group. Patients will be followed in both the Humira® and Methotrexate (MTX) arms for 10 years from the enrollment date into one of the treatment arms.
Key Dates
- Start date
- Jul 11, 2008
- Status verified
- Jan 2025
- Primary completion
- Feb 1, 2024
- Completion
- Feb 1, 2024
Study Design
- Enrollment
- 849 participants (actual)
Arms
- Arm: HUMIRA® Treatment ArmFor patients taking HUMIRA®
- Arm: Methotrexate Treatment ArmFor patients taking Methotrexate
Primary Outcome Measure
Incidence of Serious Adverse Events (SAEs) [ Time Frame: Up to 10 years ]
Locations (32)
Find similar trials in Phoenix, AZ
By research site
AZ Arthritis and Rheumotology Research, PLLC· Phoenix, AZCatalina Pointe Clinical Research· Tucson, AZArkansas Children's Hospital· Little Rock, ARChildren's Hospital Los Angeles· Los Angeles, CAChildren's National Medical Center· Washington D.C., DCDuplicate_Arthritis Associates South FL· Delray Beach, FL
Related Studies
- Development of a Therapeutic Endpoint in Pediatric Rheumatologic ConditionsRecruiting · Children's National Research Institute · Washington D.C., District of Columbia
- Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.PHASE3 · Recruiting · AbbVie · Phoenix, Arizona
- Pain in Juvenile ArthritisRecruiting · Washington University School of Medicine · St Louis, Missouri